Faron Pharmaceuticals (UK) Analysis
| FARN Stock | 175.00 5.00 2.94% |
Faron Pharmaceuticals Oy is overvalued with Real Value of 151.31 and Hype Value of 175.0. The main objective of Faron Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Faron Pharmaceuticals Oy is worth, separate from its market price. There are two main types of Faron Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Faron Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Faron Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Faron Pharmaceuticals stock is traded in UK on London Exchange, with the market opening at 08:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in UK. Faron Pharmaceuticals is usually not traded on Summer Bank Holiday, Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, May Day Bank Holiday, Spring Bank Holiday ( 2025 ). Faron Stock trading window is adjusted to Europe/London timezone.
Faron |
Faron Stock Analysis Notes
About 32.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.32. Faron Pharmaceuticals had not issued any dividends in recent years. The entity had 5000:4999 split on the 7th of August 2019. To learn more about Faron Pharmaceuticals Oy call the company at 358 2469 5151 or check out https://www.faron.com.Faron Pharmaceuticals Quarterly Total Revenue |
|
Faron Pharmaceuticals Investment Alerts
| Faron Pharmaceuticals generated a negative expected return over the last 90 days | |
| Faron Pharmaceuticals has high historical volatility and very poor performance | |
| Net Loss for the year was (30.94 M) with profit before overhead, payroll, taxes, and interest of 803 K. | |
| Faron Pharmaceuticals generates negative cash flow from operations | |
| About 32.0% of the company shares are held by company insiders |
Faron Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 177.86 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Faron Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Faron Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Management Efficiency
Faron Pharmaceuticals has return on total asset (ROA) of (0.7) % which means that it has lost $0.7 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (39.615) %, meaning that it generated substantial loss on money invested by shareholders. Faron Pharmaceuticals' management efficiency ratios could be used to measure how well Faron Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Faron Pharmaceuticals' Total Assets are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 2.5 M in 2024, whereas Intangible Assets are likely to drop slightly above 691.5 K in 2024.Leadership effectiveness at Faron Pharmaceuticals Oy is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Beta 0.329 | Return On Assets (0.70) | Return On Equity (39.62) |
Technical Drivers
As of the 19th of December, Faron Pharmaceuticals shows the Mean Deviation of 2.53, variance of 13.45, and Standard Deviation of 3.67. Faron Pharmaceuticals technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Faron Pharmaceuticals mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Faron Pharmaceuticals is priced favorably, providing market reflects its regular price of 175.0 per share.Faron Pharmaceuticals Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Faron Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Faron Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Faron Pharmaceuticals Outstanding Bonds
Faron Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Faron Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Faron bonds can be classified according to their maturity, which is the date when Faron Pharmaceuticals Oy has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Faron Pharmaceuticals Predictive Daily Indicators
Faron Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Faron Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Faron Pharmaceuticals Forecast Models
Faron Pharmaceuticals' time-series forecasting models are one of many Faron Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Faron Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Faron Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Faron Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Faron shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Faron Pharmaceuticals. By using and applying Faron Stock analysis, traders can create a robust methodology for identifying Faron entry and exit points for their positions.
Faron Pharmaceuticals is entity of United Kingdom. It is traded as Stock on LSE exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Faron Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Additional Tools for Faron Stock Analysis
When running Faron Pharmaceuticals' price analysis, check to measure Faron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Faron Pharmaceuticals is operating at the current time. Most of Faron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Faron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Faron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Faron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.